P66 A multicenter phase II randomized study of docetaxel/gemcitabine weekly followed by erlotinib after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA) (gfpc*0504): preliminary results

2009 ◽  
Vol 72 (1) ◽  
pp. S42
Author(s):  
H. Le Caer ◽  
F. Barlesi ◽  
R. Corre ◽  
H. Jullian ◽  
D. Balas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Geriatric Assessment ◽  
Phase Ii ◽  
Comprehensive Geriatric Assessment ◽  
Randomized Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicenter Phase

scholarly journals Weekly Paclitaxel Combined with Monthly Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

2006 ◽  
Vol 1 (4) ◽  
pp. 328-334 ◽  
Author(s):  
Jean-Louis Pujol ◽  
Bernard Milleron ◽  
Olivier Molinier ◽  
Elisabeth Quoix ◽  
Alain Depierre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Weekly Paclitaxel ◽  
Small Cell Lung ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document